Prevalence of Sarcopenia Among Elderly Living in Care Facilities in Klang Valley, Malaysia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

205 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-12-06

Study Completion Date

2017-12-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of this study was to investigate the prevalence of age-related progressive decline in muscle mass and strength (Sarcopenia) among Malaysian elderly residing in long-term care facilities. It is a very important condition to study as it is associated with high incidence of fall, hospitalization and mortality.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sarcopenia Screening in Elderly Individuals

NCT06012422

Sarcopenia

UNKNOWN NA

Clinical Evaluation, Biomarkers and Metabolomics of Sarcopenia in Frail Older Adults at Ambulatory Clinics

NCT02073370

Frailty Sarcopenia

UNKNOWN

Health and Nutrition Status of Chinese Elderly

NCT02089906

Malnutrition Sarcopenia

COMPLETED

Prevalence and Associated Factors of Sarcopenia Among Elderly Patients in Osteoporosis Clinic

NCT05688150

Sarcopenia Osteoporosis

COMPLETED

Prevalence of Sarcopenia-Promoting Medicines in Patients With Sarcopenia and Falls

NCT07127692

Sarcopenia in Elderly Falls

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Over the past few decades, one condition that prominently affects the muscular system, known as sarcopenia, has captured the attention of healthcare experts and researchers. Sarcopenia is a geriatric syndrome characterized by the involuntary, gradual and generalized deterioration of skeletal muscle mass and strength with advancing age. It is to be noted that while sarcopenia is predominantly a syndrome of the elderly, its development may also be observed in various conditions such as disuse, malnutrition and cachexia, all of which are not exclusive only to the elderly. As of now, there are still ongoing research on an international scale with regards to its epidemiology, risk factors, causative factors, adverse clinical complications, prevention and treatment.

Beginning in 1st of October, 2016, Centres for Disease Control and Prevention (CDC) has finally officialised an International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10- CM) code for sarcopenia after its final proposal since April 2015. This establishment has enabled comprehensible clinical guidelines for diagnosis and treatment of sarcopenia, as well as separate reporting and data collection for sarcopenia in the medical community.

In essence, sarcopenia appears to be one of the most important causes of functional impairment, physical disability and loss of independence in older adults and a prevalence study will help to estimate the deleterious effects of this condition on the elderly living in the care facility, who happen to be the less privileged group as compared to their counterparts dwelling in the community.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia Sarcopenic Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sarcopenia assessment

Sarcopenia assessment by measurement of Skeletal Muscle mass index, hand grip strength and usual gait speed for 5 meter distance, as per the guidelines of Asia Working group for Sarcopenia study, was carried out.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Height and weight measurements Skeletal muscle mass index Hand grip strength Gait speed

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently residing in a long-term care facility
* Ability to walk, with or without the use of any walking aid
* Citizen of Malaysia

Exclusion Criteria

* Inability to stand for height, weight and gait speed assessments
* Presence of cardiac pacemaker
* Presence of artificial limbs / prosthesis / metal implants
* Difficult or dangerous behaviours
* Severe cardiac, pulmonary, or musculoskeletal disorders
* Severe cognitive impairment or any disability that makes communication impossible
* Presence of terminal illness
* Co-morbidities associated with high risk of falls (e.g. Parkinson's disease or CVA) or that may directly influence affect gait speed

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes